Transient receptor potential mucolipin (TRPML)
proteins belong to the TRP superfamily of non-selective
cation channels. The TRPML1, -2, and -3
proteins are encoded by Mucolipin (MCOLN)-1, -2 and -3 genes, respectively. TRPML1 has been associated with
mucolipidosis type IV (MLIV), while no disease phenotype has been linked with TRPML2 or -3
protein. The TRPML
proteins share high sequence similarities, form hetero-tetramers, and serve in membrane trafficking, autophagy, and
metal homeostasis. Previous studies suggest that TRPML2 serves a role in the immune system; however, the evidence is mostly indirect. We hypothesize that if TRPML2 is involved in immune function its expression would be likely regulated by an immune-associated
transcription factor protein. Thus, we set out to identify the core promoter region and the
transcription factor responsible for MCOLN2 gene expression. Using dual-
luciferase assay and over-expression analyses, we reveal for the first time that B-cell lineage specific activator
protein (BSAP), also known as paired box 5 (PAX5), controls MCOLN2 expression. Specifically, heterologous expression of PAX5 in HEK-293 cells significantly increased endogenous MCOLN2 transcript and TRPML2
protein levels, while RNA interference targeting endogenous PAX5 reduced its effect. Site-directed mutagenesis studies showed that the core promoter and PAX5 binding region to be between -79 and -60 base pairs upstream of the transcriptional start site. Thus, our findings add to a growing list of evidence for TRPML2's possible involvement in the immune system. The knowledge gained from this study could be used to further characterize the role of TRPML2 in B-cell development and function.